Mounia Chaoui
Bioinformatics and system biology
HORAMA
France
Biography
Mounia CHAOUI is a general partner at Turenne Capital since 2013, where she is responsible for growth/buyout capital in the healthcare sector. Mounia has previously worked as a life science investor with Ventech, INSERM Transfert Initiative, and Atlas Venture. She is a board member of several companies that have been acquired (e.g., Biovex, sold to Amgen for up to $1B) or have gone public on NASDAQ or Euronext (e.g., Tigenix). Mounia holds a PhD in Biophysics and a degree in Engineering from Ecole Centrale, Paris.
Research Interest
Bioinformatics and system biology
